TWI662032B - Method of producing thiamethoxam - Google Patents
Method of producing thiamethoxam Download PDFInfo
- Publication number
- TWI662032B TWI662032B TW104116747A TW104116747A TWI662032B TW I662032 B TWI662032 B TW I662032B TW 104116747 A TW104116747 A TW 104116747A TW 104116747 A TW104116747 A TW 104116747A TW I662032 B TWI662032 B TW I662032B
- Authority
- TW
- Taiwan
- Prior art keywords
- ammonium
- chloride
- item
- patent application
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 239000005941 Thiamethoxam Substances 0.000 title claims abstract description 43
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 title claims abstract description 43
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 69
- VRMUIVKEHJSADG-UHFFFAOYSA-N 2-chloro-5-(chloromethyl)-1,3-thiazole Chemical compound ClCC1=CN=C(Cl)S1 VRMUIVKEHJSADG-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 17
- XSAKKOPXSHNEFG-UHFFFAOYSA-N n-(3-methyl-2h-1,3,5-oxadiazin-4-ylidene)nitramide Chemical compound CN1COC=NC1=N[N+]([O-])=O XSAKKOPXSHNEFG-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims description 20
- 239000002585 base Substances 0.000 claims description 17
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 14
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 12
- -1 alkaline earth metal carbonate Chemical class 0.000 claims description 10
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 7
- 235000011181 potassium carbonates Nutrition 0.000 claims description 7
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 claims description 6
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 4
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 claims description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- LLNAMUJRIZIXHF-CLFYSBASSA-N (z)-2-methyl-3-phenylprop-2-en-1-ol Chemical compound OCC(/C)=C\C1=CC=CC=C1 LLNAMUJRIZIXHF-CLFYSBASSA-N 0.000 claims description 2
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- VJGNLOIQCWLBJR-UHFFFAOYSA-M benzyl(tributyl)azanium;chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CC1=CC=CC=C1 VJGNLOIQCWLBJR-UHFFFAOYSA-M 0.000 claims description 2
- CHQVQXZFZHACQQ-UHFFFAOYSA-M benzyl(triethyl)azanium;bromide Chemical compound [Br-].CC[N+](CC)(CC)CC1=CC=CC=C1 CHQVQXZFZHACQQ-UHFFFAOYSA-M 0.000 claims description 2
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 2
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 2
- 150000003983 crown ethers Chemical class 0.000 claims description 2
- 239000012973 diazabicyclooctane Substances 0.000 claims description 2
- KKWUACQXLWHLCX-UHFFFAOYSA-N hydron;tetradecan-1-amine;chloride Chemical compound Cl.CCCCCCCCCCCCCCN KKWUACQXLWHLCX-UHFFFAOYSA-N 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 150000004714 phosphonium salts Chemical group 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 2
- ZXPZGTHHOVGSSO-UHFFFAOYSA-M tetradodecylazanium;acetate Chemical compound CC([O-])=O.CCCCCCCCCCCC[N+](CCCCCCCCCCCC)(CCCCCCCCCCCC)CCCCCCCCCCCC ZXPZGTHHOVGSSO-UHFFFAOYSA-M 0.000 claims description 2
- AHQMUYHFUYRUJV-UHFFFAOYSA-N tetradodecylazanium;nitrate Chemical compound [O-][N+]([O-])=O.CCCCCCCCCCCC[N+](CCCCCCCCCCCC)(CCCCCCCCCCCC)CCCCCCCCCCCC AHQMUYHFUYRUJV-UHFFFAOYSA-N 0.000 claims description 2
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 claims description 2
- 229940073455 tetraethylammonium hydroxide Drugs 0.000 claims description 2
- LRGJRHZIDJQFCL-UHFFFAOYSA-M tetraethylazanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)CC LRGJRHZIDJQFCL-UHFFFAOYSA-M 0.000 claims description 2
- SYZCZDCAEVUSPM-UHFFFAOYSA-M tetrahexylazanium;bromide Chemical compound [Br-].CCCCCC[N+](CCCCCC)(CCCCCC)CCCCCC SYZCZDCAEVUSPM-UHFFFAOYSA-M 0.000 claims description 2
- ODTSDWCGLRVBHJ-UHFFFAOYSA-M tetrahexylazanium;chloride Chemical compound [Cl-].CCCCCC[N+](CCCCCC)(CCCCCC)CCCCCC ODTSDWCGLRVBHJ-UHFFFAOYSA-M 0.000 claims description 2
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 claims description 2
- RXMRGBVLCSYIBO-UHFFFAOYSA-M tetramethylazanium;iodide Chemical compound [I-].C[N+](C)(C)C RXMRGBVLCSYIBO-UHFFFAOYSA-M 0.000 claims description 2
- SNNIPOQLGBPXPS-UHFFFAOYSA-M tetraoctylazanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC SNNIPOQLGBPXPS-UHFFFAOYSA-M 0.000 claims description 2
- BGQMOFGZRJUORO-UHFFFAOYSA-M tetrapropylammonium bromide Chemical compound [Br-].CCC[N+](CCC)(CCC)CCC BGQMOFGZRJUORO-UHFFFAOYSA-M 0.000 claims description 2
- CMFMTXJHXCLMMS-UHFFFAOYSA-M tributyl(heptyl)azanium;bromide Chemical compound [Br-].CCCCCCC[N+](CCCC)(CCCC)CCCC CMFMTXJHXCLMMS-UHFFFAOYSA-M 0.000 claims description 2
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 claims description 2
- MQAYPFVXSPHGJM-UHFFFAOYSA-M trimethyl(phenyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)C1=CC=CC=C1 MQAYPFVXSPHGJM-UHFFFAOYSA-M 0.000 claims description 2
- HADKRTWCOYPCPH-UHFFFAOYSA-M trimethylphenylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C1=CC=CC=C1 HADKRTWCOYPCPH-UHFFFAOYSA-M 0.000 claims description 2
- QAQSNXHKHKONNS-UHFFFAOYSA-N 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide Chemical compound CCN1C(O)=C(C(N)=O)C(C)=CC1=O QAQSNXHKHKONNS-UHFFFAOYSA-N 0.000 claims 1
- JTQVQSNXYCMMNM-UHFFFAOYSA-N 2-(2,3-dimethylphenyl)propane-2-sulfonic acid Chemical compound CC=1C(=C(C(S(=O)(=O)O)(C)C)C=CC=1)C JTQVQSNXYCMMNM-UHFFFAOYSA-N 0.000 claims 1
- AJEUSSNTTSVFIZ-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;hydroxide Chemical compound [OH-].C[N+](C)(C)CCCO AJEUSSNTTSVFIZ-UHFFFAOYSA-M 0.000 claims 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims 1
- 150000008041 alkali metal carbonates Chemical class 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 1
- GJPICBWGIJYLCB-UHFFFAOYSA-N dodecyl phenylmethanesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)CC1=CC=CC=C1 GJPICBWGIJYLCB-UHFFFAOYSA-N 0.000 claims 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims 1
- OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 claims 1
- WYXIGTJNYDDFFH-UHFFFAOYSA-Q triazanium;borate Chemical compound [NH4+].[NH4+].[NH4+].[O-]B([O-])[O-] WYXIGTJNYDDFFH-UHFFFAOYSA-Q 0.000 claims 1
- IPILPUZVTYHGIL-UHFFFAOYSA-M tributyl(methyl)azanium;chloride Chemical compound [Cl-].CCCC[N+](C)(CCCC)CCCC IPILPUZVTYHGIL-UHFFFAOYSA-M 0.000 claims 1
- 239000002904 solvent Substances 0.000 abstract description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000005906 Imidacloprid Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 3
- 229940056881 imidacloprid Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UKDOTCFNLHHKOF-FGRDZWBJSA-N (z)-1-chloroprop-1-ene;(z)-1,2-dichloroethene Chemical group C\C=C/Cl.Cl\C=C/Cl UKDOTCFNLHHKOF-FGRDZWBJSA-N 0.000 description 2
- DGBFPSVUFUDQNA-UHFFFAOYSA-N 2-chloro-3-isothiocyanatoprop-1-ene Chemical compound ClC(=C)CN=C=S DGBFPSVUFUDQNA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- GAYLOVDFGKQKCJ-UHFFFAOYSA-N n-(3-methyl-2,6-dihydro-1,3,5-oxadiazin-4-yl)nitramide Chemical compound CN1COCN=C1N[N+]([O-])=O GAYLOVDFGKQKCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- SZRSEFNUSHACPD-UHFFFAOYSA-M 1-hexylpyridin-1-ium;bromide Chemical compound [Br-].CCCCCC[N+]1=CC=CC=C1 SZRSEFNUSHACPD-UHFFFAOYSA-M 0.000 description 1
- BJRRHBMKDXBQBE-UHFFFAOYSA-N 1-methyl-1-nitroguanidine Chemical compound NC(=N)N(C)[N+]([O-])=O BJRRHBMKDXBQBE-UHFFFAOYSA-N 0.000 description 1
- FALCMQXTWHPRIH-UHFFFAOYSA-N 2,3-dichloroprop-1-ene Chemical compound ClCC(Cl)=C FALCMQXTWHPRIH-UHFFFAOYSA-N 0.000 description 1
- KIZQNNOULOCVDM-UHFFFAOYSA-M 2-hydroxyethyl(trimethyl)azanium;hydroxide Chemical compound [OH-].C[N+](C)(C)CCO KIZQNNOULOCVDM-UHFFFAOYSA-M 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241000208199 Buxus sempervirens Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 241001414720 Cicadellidae Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241001466042 Fulgoromorpha Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000258916 Leptinotarsa decemlineata Species 0.000 description 1
- LGHJQOKBRBMVEB-UHFFFAOYSA-N N-(1,3,5-oxadiazin-4-ylidene)nitramide Chemical compound [N+](=O)([O-])N=C1N=COC=N1 LGHJQOKBRBMVEB-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- XBECMBTYAXAQIK-UHFFFAOYSA-N [Cl-].C(CCC)C([NH2+]C)(CCCC)CCCC Chemical compound [Cl-].C(CCC)C([NH2+]C)(CCCC)CCCC XBECMBTYAXAQIK-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 238000004920 integrated pest control Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000004686 pentahydrates Chemical group 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- HIFXHEXRVMWOAG-UHFFFAOYSA-M phenylmethanesulfonate;tetramethylazanium Chemical compound C[N+](C)(C)C.[O-]S(=O)(=O)CC1=CC=CC=C1 HIFXHEXRVMWOAG-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000002602 strong irritant Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- FBEVECUEMUUFKM-UHFFFAOYSA-M tetrapropylazanium;chloride Chemical compound [Cl-].CCC[N+](CCC)(CCC)CCC FBEVECUEMUUFKM-UHFFFAOYSA-M 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
本文提供了一種製備噻蟲嗪的方法:
在包含二甲基甲醯胺(dimethylformamide,DMF)的溶劑系統、相轉移催化劑和鹼的存在下進行反應。 The reaction is performed in the presence of a solvent system containing dimethylformamide (DMF), a phase transfer catalyst, and a base.
Description
本發明涉及一種製備具有以下結構的3-(2-氯-1,3-噻唑-5-基甲基)-5-甲基-1,3,5-噁二嗪-4-亞基(硝基)胺(噻蟲嗪(thiamethoxam))的方法:
Solovay在1978年報導了具有殺蟲活性的硝基亞甲基雜環化合物(“噻蟲嗪合成方法的研究”,Tao,Xian-jian;Huang,Chao-qun;Luo,Liang-ming,湖南化學工業研究所,中國長沙,現代農藥(2006),5(1),第11-13頁)。 Solovay reported a nitromethylene heterocyclic compound with insecticidal activity in 1978 ("Study on the Synthesis of Thiamethoxam", Tao, Xian-jian; Huang, Chao-qun; Luo, Liang-ming, Hunan Chemistry Industrial Research Institute, Changsha, China, Modern Pesticides (2006), 5 (1), pp. 11-13).
近年來,很多研究者通過研究官能團變化來關注硝基亞甲基雜環化合物的衍生物。在1980年代中期,拜爾公司(Bayer)成功地開發了商業規模的第一種新煙鹼類殺蟲劑,(E)-1-(6-氯-3-吡啶基甲基)-N-硝基亞咪唑烷-2-基胺(吡蟲啉(imidacloprid))。由於其新的作用模式、選擇性、效率和廣譜環境相容性的優良特徵,吡蟲啉在本領域引起了巨大關注,使得人們對新煙鹼類似物及其合成進行廣泛的研究。迄今為止,該研究和開發的結果使得超過12種產品被商業化,其中噻蟲嗪是最為突出的。 In recent years, many researchers have focused on derivatives of nitromethylene heterocyclic compounds by studying functional group changes. In the mid-1980s, Bayer successfully developed the first commercial-scale neonicotinoid insecticide, ( E ) -1- (6-chloro-3-pyridylmethyl) -N- Nitroimidazolidin-2-ylamine (imidacloprid). Because of its new mode of action, selectivity, efficiency, and broad-spectrum environmental compatibility, imidacloprid has attracted great attention in the field, leading to extensive research on neonicotinoids and their synthesis. As a result of this research and development, more than 12 products have been commercialized, of which thiamethoxam is the most prominent.
P.Maienfisch的“噻蟲嗪和相關化合物的合成和性質(Synthesis and Properties of Thiamethoxam and Related Compounds)”,Z.Naturforsch.61b,(2006),第353-359頁描述了噻蟲嗪開發和商業化。 P. Maienfisch, "Synthesis and Properties of Thiamethoxam and Related Compounds", Z. Naturforsch. 61b , (2006), pages 353-359 describe the development and commercialization of thiamethoxam Into.
噻蟲嗪是由硫雜煙鹼亞類開發的第一個商業化的新煙鹼類殺蟲劑,在1985年開始的對新煙鹼類物質進行研究的過程中被發現。對吡蟲啉的硝基亞胺基-雜環進行新的變化而發現4-硝基亞胺基-1,3,5-噁二嗪具有高殺蟲活性。在這些化合物中,確定噻蟲嗪是最佳化合物並選擇噻蟲嗪進行世界範圍內的研究。 Thiamethoxam is the first commercially available neonicotinoid insecticide developed from the thianicotine subclass. It was discovered during the study of neonicotinoids starting in 1985. New changes were made to the nitroimino-heterocycle of imidacloprid and 4-nitroimino-1,3,5-oxadiazine was found to have high insecticidal activity. Among these compounds, thiamethoxam was identified as the best compound and thiamethoxam was selected for worldwide research.
噻蟲嗪通過與煙鹼乙醯膽鹼受體結合進行作用。它表現出傑出的系統性特徵,並對大範圍的商業上非常重要的害蟲,例如,蚜蟲、葉蟬、粉虱、牧草蟲、稻飛蝨、科羅拉多土豆甲蟲、跳甲和切根蟲以及一些鱗翅類物種提供良好的控制。此外,證明噻蟲嗪具有對一些病毒轉移具有強的預防效果。噻蟲嗪被開發為同時用於葉/土壤應用,以及在全世界的大部分農作物中用作種子處理。低使用率、靈活的應用方法、良好的效率、長效殘餘活性和有利的安全分佈使得噻蟲嗪特別適合很多作物系統的現代化集成害蟲控制專案。 Thiamethoxam works by binding to the nicotine acetamidine receptor. It exhibits outstanding systemic characteristics and is important to a wide range of commercially important pests such as aphids, leafhoppers, whitefly, herbivores, rice planthoppers, Colorado potato beetle, beetle and root-cutting insects, and some Lepidopteran species provide good control. In addition, thiamethoxam has been shown to have a strong preventive effect on the transfer of some viruses. Thiamethoxam was developed for both leaf / soil applications and as seed treatment in most crops worldwide. Low utilization, flexible application methods, good efficiency, long-lasting residual activity and favorable safety distribution make thiamethoxam particularly suitable for modern integrated pest control projects in many crop systems.
合成噻蟲嗪有多種不同的路徑。最直截了當和普遍的方法是根據以下反應順序由3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑製備噻蟲嗪:
但是,關鍵的中間體2-氯-5-氯甲基噻唑極不穩定,容易分解。因此,其穩定性對於噻蟲嗪的最終產率來說非常重要。2-氯-5-氯甲基噻唑還是一種強刺激物,其對噻蟲嗪的不完全轉化是非常不希望的。 However, the key intermediate, 2-chloro-5-chloromethylthiazole, is extremely unstable and easily decomposes. Therefore, its stability is very important for the final yield of thiamethoxam. 2-Chloro-5-chloromethylthiazole is also a strong irritant, and its incomplete conversion of thiamethoxam is highly undesirable.
WO 01/00623涉及一種製備硝基胍-和硝基烯胺衍生物的方法。公開了該方法適於形成噻蟲嗪,其中起始材料是3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑,如上所述。該方法包括將起始材料與相轉移催化劑和鹼反應。WO 01/00623列出了一長串用於 該方法的可能的溶劑,例如碳酸酯、特別是碳酸二甲酯、二甲基甲醯胺、乙腈、二甲基亞碸、丙酮,甲基乙基酮、乙酸乙酯。WO 01/00623特別示出在季銨鹽、碳酸鉀以及作為溶劑的碳酸二甲酯的存在下通過上述方法形成噻蟲嗪。報導的噻蟲嗪的最終產率僅為74%。該產率不適於以商業規模大量生產噻蟲嗪。 WO 01/00623 relates to a method for preparing nitroguanidine- and nitroenamine derivatives. The method is disclosed as being suitable for the formation of thiamethoxam in which the starting materials are 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine and 2-chloro-5-chloromethyl Thiazole, as described above. The method includes reacting a starting material with a phase transfer catalyst and a base. WO 01/00623 lists a long list for Possible solvents for this method are, for example, carbonates, in particular dimethyl carbonate, dimethylformamide, acetonitrile, dimethylsulfinium, acetone, methyl ethyl ketone, ethyl acetate. WO 01/00623 particularly shows the formation of thiamethoxam by the method described above in the presence of a quaternary ammonium salt, potassium carbonate and dimethyl carbonate as a solvent. The reported final yield of thiamethoxam was only 74%. This yield is not suitable for the large-scale production of thiamethoxam on a commercial scale.
如上所述,P.Maienfisch,“噻蟲嗪及其相關化合物的合成和性質”(Synthesis and Properties of Thiamethoxam and Related Compounds),Z.Naturforsch.61b,(2006),第353-359頁,公開了由3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑製備噻蟲嗪。該反應在碳酸鉀以及作為溶劑的二甲基甲醯胺(DMF)的存在下進行。所述噻蟲嗪的產率為71%。同樣,如此低的產率使該方法不適用於商業規模。 As mentioned above, P. Maienfisch, "Synthesis and Properties of Thiamethoxam and Related Compounds", Z. Naturforsch. 61b , (2006), pages 353-359, disclose Thiamethoxam was prepared from 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine and 2-chloro-5-chloromethylthiazole. This reaction is performed in the presence of potassium carbonate and dimethylformamide (DMF) as a solvent. The yield of the thiamethoxam was 71%. Also, such a low yield makes this method unsuitable for commercial scale.
因此,需要製備噻蟲嗪的改進的方法。如果改進的方法能使噻蟲嗪的產率增加則是有利的。此外,如果反應條件有利於2-氯-5-氯甲基噻唑的穩定性也是有利的。 Therefore, there is a need for an improved method for preparing thiamethoxam. It would be advantageous if the improved method could increase the yield of thiamethoxam. In addition, it is also advantageous if the reaction conditions are favorable for the stability of 2-chloro-5-chloromethylthiazole.
現已發現製備噻蟲嗪的改進的方法。具體地,發現在鹼、相轉移催化劑和包括二甲基甲醯胺(DMF)的溶劑系統的存在下,將3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑反應能以極高的產率製備噻蟲嗪。具體地,發現該方法以高產率製得噻蟲嗪,同時得到最少量的不希望的副產物。似乎上述反應條件有利於2-氯-5-氯甲基噻唑的穩定性,同時仍能使反應以高產率進行從而轉化為噻蟲嗪。 Improved methods of preparing thiamethoxam have now been discovered. Specifically, it was found that 3-methyl-N-nitro-1,3,5-oxadiazine-4 was present in the presence of a base, a phase transfer catalyst, and a solvent system including dimethylformamide (DMF). -The reaction of imine with 2-chloro-5-chloromethylthiazole can produce thiamethoxam in extremely high yields. In particular, this method was found to produce thiamethoxam in high yields while obtaining a minimal amount of undesirable by-products. It appears that the above reaction conditions are favorable for the stability of 2-chloro-5-chloromethylthiazole, while still allowing the reaction to proceed in high yields to convert to thiamethoxam.
相應地,本發明提供一種製備噻蟲嗪的方法:
在包含二甲基甲醯胺(DMF)的溶劑系統、相轉移催化劑和鹼的存在下進行反應。 The reaction is performed in the presence of a solvent system containing dimethylformamide (DMF), a phase transfer catalyst, and a base.
令人驚訝地發現在相轉移催化劑和鹼的存在下與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺反應形成噻蟲嗪時,關鍵的中間體2-氯-5-氯甲基噻唑在包含DMF的溶劑系統中是高度穩定的。特別令人驚訝的是以極高的純度和極高的產率製得最終產物。具體地,本發明的方法能以高達98%的純度和超過90%的產率製備噻蟲嗪。這使得本發明的方法在以商業規模應用時特別有利。 It was surprisingly found that when reacting with 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine to form thiamethoxam in the presence of a phase transfer catalyst and a base, a key intermediate 2-Chloro-5-chloromethylthiazole is highly stable in solvent systems containing DMF. It is particularly surprising that the final product is produced with extremely high purity and very high yields. Specifically, the method of the present invention enables the preparation of thiamethoxam with a purity of up to 98% and a yield of more than 90%. This makes the method of the invention particularly advantageous when applied on a commercial scale.
本發明的方法採用包含二甲基甲醯胺(DMF)的溶劑系統。DMF可以與一種或多種其它溶劑,例如有機溶劑一起組合使用。更優選地,本發明方法所使用的溶劑系統基本上由DMF組成。 The method of the present invention uses a solvent system containing dimethylformamide (DMF). DMF can be used in combination with one or more other solvents, such as organic solvents. More preferably, the solvent system used in the method of the invention consists essentially of DMF.
所述方法還使用相轉移催化劑。合適的相轉移催化劑是本領域已知的。合適的相轉移催化劑的例子如WO 01/00623所述,包括聚合物相轉移催化劑、季銨鹽、季鏻鹽、冠醚、螯合劑、DABCO(1,4-二氮雜二環[2.2.2]辛烷)和DBU(1,5-二氮雜二環[4.3.0]壬-5-烯)及其季銨鹽。 The method also uses a phase transfer catalyst. Suitable phase transfer catalysts are known in the art. Examples of suitable phase transfer catalysts are described in WO 01/00623, including polymer phase transfer catalysts, quaternary ammonium salts, quaternary phosphonium salts, crown ethers, chelating agents, DABCO (1,4-diazabicyclo [2.2. 2] octane) and DBU (1,5-diazabicyclo [4.3.0] non-5-ene) and their quaternary ammonium salts.
優選地,所述相轉移催化劑是季銨鹽。瑞士布克斯市伏路卡公司(Fluka,Buchs,Switzerland)的論文“相轉移催化劑”,1986版,第7-25頁列出合適的季銨鹽。 Preferably, the phase transfer catalyst is a quaternary ammonium salt. A suitable quaternary ammonium salt is listed in the paper "Phase Transfer Catalyst" by Fluka, Buchs, Switzerland, 1986 edition, pages 7-25.
特別優選的季銨鹽是例如三甲基苄基氯化銨、三乙基苄基氯化銨、三丁基苄基氯化銨、三乙基苄基溴化銨、三甲基苄基甲醇銨、三甲基苄基氫氧化銨(triton B)、縮水甘油基三甲基氯化銨、十六烷基-三甲基氯化銨、十六烷基-三甲基溴化銨、十六烷基-溴化吡啶鎓、十六烷基-氯化吡啶鎓、2-羥乙基-三甲基氯化銨、2-羥乙基-三甲基氫氧化銨、苯基三甲基氯化銨、苯基三甲基氫氧化銨、四丁基氯化銨、四丁基溴化銨、四丁基氫氧化銨、四丁基四氟硼酸銨、四丁基硝酸銨、四癸基氯化銨、四(十二烷基)-乙酸銨、四乙基氯化銨、四乙基氫氧化銨、四(十二烷基)硝酸銨、四(十二烷基)甲苯磺酸銨、四己基氯化銨、四己基溴化銨、四甲基氯化銨、四甲基-溴化銨、四甲基氫氧化銨、四甲基碘化銨、四甲基甲苯磺酸銨、四辛基氯化銨、四丙基氯化銨、四丙基溴化銨、三丁基甲基氯化銨、三丁基庚基溴化銨,和氫氧化季銨,具體為五水合形式的四甲基氫氧化銨。優選的季銨鹽是三乙基苄基氯化銨(triethyl benzyl ammonium chloride,TEBA)。 Particularly preferred quaternary ammonium salts are, for example, trimethylbenzylammonium chloride, triethylbenzylammonium chloride, tributylbenzylammonium chloride, triethylbenzylammonium bromide, trimethylbenzylmethanol Ammonium, trimethyl benzyl ammonium hydroxide (triton B), glycidyl trimethyl ammonium chloride, cetyl-trimethyl ammonium chloride, cetyl-trimethyl ammonium bromide, ten Hexyl-pyridinium bromide, cetyl-pyridinium chloride, 2-hydroxyethyl-trimethylammonium chloride, 2-hydroxyethyl-trimethylammonium hydroxide, phenyltrimethyl Ammonium chloride, phenyltrimethylammonium hydroxide, tetrabutylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium hydroxide, tetrabutylammonium tetrafluoroborate, tetrabutylammonium nitrate, tetradecyl Ammonium chloride, tetra (dodecyl) -ammonium acetate, tetraethylammonium chloride, tetraethylammonium hydroxide, tetra (dodecyl) ammonium nitrate, tetra (dodecyl) toluenesulfonic acid Ammonium, tetrahexylammonium chloride, tetrahexylammonium bromide, tetramethylammonium chloride, tetramethyl-ammonium bromide, tetramethylammonium hydroxide, tetramethylammonium iodide, tetramethylammonium toluenesulfonate , Tetraoctyl ammonium chloride, tetrapropyl ammonium chloride, tetrapropyl ammonium bromide, tributyl Methylmethylammonium chloride, tributylheptylammonium bromide, and quaternary ammonium hydroxide, specifically tetramethylammonium hydroxide in a pentahydrate form. A preferred quaternary ammonium salt is triethyl benzyl ammonium chloride (TEBA).
本發明的方法也在鹼的存在下進行。合適的鹼是本領域已知的,並且市售可得。所述鹼優選是碳酸金屬鹽,更優選鹼金屬或鹼土金屬的碳酸鹽。優選地,所述鹼選自碳酸鈣、碳酸鈉、碳酸氫鈉、碳酸鉀、碳酸氫鉀及其混合物。碳酸鉀是用於本發明方法的特別優選的鹼。 The method of the present invention is also performed in the presence of a base. Suitable bases are known in the art and are commercially available. The base is preferably a metal carbonate, more preferably an alkali or alkaline earth metal carbonate. Preferably, the base is selected from the group consisting of calcium carbonate, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, and mixtures thereof. Potassium carbonate is a particularly preferred base for use in the process of the invention.
在本發明的方法中,2-氯-5-氯甲基噻唑與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺反應。優選反應在升高的溫度下進行,具體地,在50-75℃、更優選55-70℃,更優選60-70℃的範圍進行。 In the method of the present invention, 2-chloro-5-chloromethylthiazole is reacted with 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine. The reaction is preferably carried out at an elevated temperature, specifically, in a range of 50-75 ° C, more preferably 55-70 ° C, and more preferably 60-70 ° C.
在該方法中,2-氯-5-氯甲基噻唑和3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺以1:1的化學計量比進行反應。但是,優選2-氯-5-氯甲基噻唑相對於3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺稍微過量,優選過量1-10%,更優選約為5%。 In this method, 2-chloro-5-chloromethylthiazole and 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine are reacted in a stoichiometric ratio of 1: 1. . However, it is preferred that 2-chloro-5-chloromethylthiazole is slightly excessive relative to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine, preferably an excess of 1-10%, more preferably It is preferably about 5%.
所述鹼在反應混合物中以任意合適的量存在。優選地,所述鹼與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺的重量比為1.1:1至2:1,更優選1.4:1至1.8:1,在很多實施方式中,比例為約1.7:1是合適的。 The base is present in the reaction mixture in any suitable amount. Preferably, the weight ratio of the base to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine is from 1.1: 1 to 2: 1, more preferably from 1.4: 1 to 1.8 : 1. In many embodiments, a ratio of about 1.7: 1 is suitable.
所述相轉移催化劑在反應混合物中以任意合適的量存在。優選地,所述相轉移催化劑與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺的重量比約為0.1:1至0.3:1,更優選約為0.2:1。 The phase transfer catalyst is present in the reaction mixture in any suitable amount. Preferably, the weight ratio of the phase transfer catalyst to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine is about 0.1: 1 to 0.3: 1, more preferably about 0.2: 1.
2-氯-5-氯甲基噻唑和3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺是本領域已知的化合物,都是市售可得的或者可以採用本領域已知的技術製備。 2-Chloro-5-chloromethylthiazole and 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine are compounds known in the art and both are commercially available Alternatively, it can be prepared using techniques known in the art.
在另一個方面中,本發明提供通過前述方法製備的噻蟲嗪。 In another aspect, the present invention provides thiamethoxam prepared by the aforementioned method.
本發明方法的實施方式通過以下具體實施例進行說明。 Embodiments of the method of the present invention are described by the following specific examples.
使用以下反應方案製備3,6-二氫-3-甲基-N-硝基-2H-1,3,5-噁二嗪-4-胺:
將100kg N-甲基-硝基胍和64kg多聚甲醛裝入1000L反應器。加入350kg乙酸,之後將所得的混合物加熱至70℃,在該溫度下保持6小時。之後,在真空下蒸餾去除溶劑(乙酸)。在攪拌下加入175kg 10%的NaOH水溶液,之後將所得混合物冷卻並攪拌30分鐘。將所得混合物排入離心機進行分離。使用Biconical乾燥器乾燥得到的濾餅,得到98kg 3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺,為白色粉末(純度97%,產率71.5%)。 100 kg of N-methyl-nitroguanidine and 64 kg of paraformaldehyde were charged into a 1000 L reactor. After 350 kg of acetic acid was added, the resulting mixture was heated to 70 ° C and maintained at this temperature for 6 hours. After that, the solvent (acetic acid) was distilled off under vacuum. 175 kg of a 10% aqueous NaOH solution was added with stirring, after which the resulting mixture was cooled and stirred for 30 minutes. The resulting mixture was discharged into a centrifuge for separation. The obtained filter cake was dried using a Biconical dryer to obtain 98 kg of 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine as a white powder (97% purity, 71.5% yield) .
使用以下反應方案製備2-氯-烯丙基硫代異腈:
在500L反應器中,將60.5kg 2,3-二氯丙烯與135kg甲苯、0.5kg TEBA(三乙基苄基氯化銨,作為催化劑)和44.1kg硫氰酸鈉混合。將得到的混合物在回流條件下(約100-105℃)加熱1.5小時,然後冷卻至室溫。加入50kg水,攪拌15分鐘,之後靜置混合物,發生相分層。在真空下從有機相中去除甲苯,使用Roots真空泵將殘留物在高真空下蒸餾。回收65kg蒸餾物2-氯-烯丙基硫代異腈,為黃色油狀液體(產率80%,純度90%)。 In a 500 L reactor, 60.5 kg of 2,3-dichloropropene were mixed with 135 kg of toluene, 0.5 kg of TEBA (triethylbenzyl ammonium chloride as a catalyst), and 44.1 kg of sodium thiocyanate. The resulting mixture was heated under reflux conditions (about 100-105 ° C) for 1.5 hours and then cooled to room temperature. 50 kg of water was added and stirred for 15 minutes, after which the mixture was allowed to stand and phase separation occurred. The toluene was removed from the organic phase under vacuum, and the residue was distilled under high vacuum using a Roots vacuum pump. 65 kg of 2-chloro-allyl thioisocyanide was recovered as a yellow oily liquid (yield 80%, purity 90%).
使用以下反應方案製備2-氯-5-(氯甲基)噻唑:
將65kg 2-氯-烯丙基硫代異腈與140kg四氯化碳在500L釉面反應器中混合。將35kg氯氣在1小時內鼓泡進入混合物,得到的混合物加熱至回流(77℃)3小時,然後冷卻至室溫。通過蒸餾去除四氯化碳。添加59kg二氯甲烷並攪拌,直至殘留物溶解,之後用86kg飽和NaHCO3溶液和40kg水洗滌溶液。得到的混合物用無水MgSO4乾燥,之後在真空下蒸餾去除二氯甲烷。最後,使用Roots真空泵在高 真空下蒸餾分離反應產物,得到61kg 2-氯-5-(氯甲基)噻唑,為黃色液體(產率84%,純度96%)。 65 kg of 2-chloro-allyl thioisocyanide and 140 kg of carbon tetrachloride were mixed in a 500 L glazed reactor. 35 kg of chlorine gas was bubbled into the mixture within 1 hour, and the resulting mixture was heated to reflux (77 ° C) for 3 hours and then cooled to room temperature. Carbon tetrachloride was removed by distillation. 59 kg of dichloromethane was added and stirred until the residue was dissolved, after which the solution was washed with 86 kg of saturated NaHCO 3 solution and 40 kg of water. The mixture obtained was dried over anhydrous MgSO 4, after the methylene chloride was removed under vacuum distillation. Finally, the reaction product was separated by distillation under high vacuum using a Roots vacuum pump to obtain 61 kg of 2-chloro-5- (chloromethyl) thiazole as a yellow liquid (yield 84%, purity 96%).
通過以下反應方案製備噻蟲嗪:
47.5kg 3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和50kg 2-氯-5-(氯甲基)噻唑進料至含350kg二甲基甲醯胺(DMF)的1000L釉面反應器中。得到的混合物進行加熱,將溫度保持在約65℃。之後,將82kg碳酸鉀和1kg三乙基苄基氯化銨(TEBA,作為催化劑)在20-40分鐘內加入反應器中。將得到的混合物反應4-5個小時,之後將混合物冷卻至室溫。將280kg水加入反應器中,攪拌混合物15分鐘,用32%的鹽酸將pH調節至6-7之間。將得到的混合物劇烈攪拌,加熱到65℃。使得到的混合物靜置30分鐘,之後排出水相,用二氯甲烷(DCM)(100kg×3)萃取3次。合併有機相,通過真空下蒸餾從混合物中去除DCM。使用Biconical乾燥器在40℃乾燥混合物,得到粗噻蟲嗪。 47.5 kg of 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine and 50 kg of 2-chloro-5- (chloromethyl) thiazole were fed to 350 kg of dimethylformamidine Amine (DMF) in a 1000 L glazed reactor. The resulting mixture was heated to maintain the temperature at about 65 ° C. Thereafter, 82 kg of potassium carbonate and 1 kg of triethylbenzyl ammonium chloride (TEBA, as a catalyst) were added to the reactor within 20-40 minutes. The resulting mixture was reacted for 4-5 hours, after which the mixture was cooled to room temperature. 280 kg of water was added to the reactor, the mixture was stirred for 15 minutes, and the pH was adjusted to 6-7 with 32% hydrochloric acid. The resulting mixture was stirred vigorously and heated to 65 ° C. The resulting mixture was allowed to stand for 30 minutes, and then the aqueous phase was discharged, and extracted three times with dichloromethane (DCM) (100 kg × 3). The organic phases were combined and the DCM was removed from the mixture by distillation under vacuum. The mixture was dried at 40 ° C using a Biconical dryer to obtain crude thiamethoxam.
將20g粗製噻蟲嗪在100g甲醇中加熱,直至完全溶解。得到的溶液回流30-60分鐘,接著冷卻至室溫。對得到的混合物進行過濾以分離固體。得到的固體用甲醇洗滌數次,在高真空下乾燥,得到工業級純的噻蟲嗪晶體(產率90.5%,純度98%)。 20 g of crude thiamethoxam was heated in 100 g of methanol until completely dissolved. The resulting solution was refluxed for 30-60 minutes and then cooled to room temperature. The resulting mixture was filtered to separate solids. The obtained solid was washed several times with methanol and dried under high vacuum to obtain technical grade pure thiamethoxam crystals (yield 90.5%, purity 98%).
在實施例4-9中重複實施例3,但是分別用碳酸二甲酯、四氯化碳、乙酸乙酯、1,2-二氯乙烯(DCE)、乙腈和甲基乙基酮作為溶劑代替DMF。實施例4-9中分別得到的噻蟲嗪的產率和純度資料與實施例3的比較示於以下表1。 Example 3 is repeated in Examples 4-9, but using dimethyl carbonate, carbon tetrachloride, ethyl acetate, 1,2-dichloroethylene (DCE), acetonitrile, and methyl ethyl ketone as solvents instead DMF. The yield and purity data of thiamethoxam obtained in each of Examples 4-9 and Table 3 are shown in Table 1 below.
從表1中可以看出,在反應方案中使用DMF作為溶劑與比較溶劑相比,DMF製備噻蟲嗪的產率明顯更高,純度明顯更高。 It can be seen from Table 1 that the use of DMF as a solvent in the reaction scheme compared with the comparison solvent, the yield of thiamethoxam by DMF is significantly higher, and the purity is significantly higher.
採用以下過程確定一系列不同溶劑中2-氯-5-(氯甲基)噻唑的穩定性:將20g 2-氯-5-(氯甲基)噻唑單獨溶解在100ml溶劑中,並攪拌2小時。使用的溶劑是DMF、碳酸二甲酯、四氯化碳、乙酸乙酯、1,2-二氯乙烯(DCE)、乙腈和甲基乙基酮。對於每種情況,隨後在真空下去除溶劑,收集乾燥的沉澱物。確定每種情況中2-氯-5-(氯甲基)噻唑和2-氯烯丙基異硫氰酸酯的量。結果列於下表2。較少量的2-氯烯丙基異硫氰酸酯表示2-氯-5-(氯甲基)噻唑具有更高的穩定性和較少的分解率。 The following procedure was used to determine the stability of 2-chloro-5- (chloromethyl) thiazole in a series of different solvents: 20 g of 2-chloro-5- (chloromethyl) thiazole was dissolved alone in 100 ml of solvent and stirred for 2 hours . The solvents used were DMF, dimethyl carbonate, carbon tetrachloride, ethyl acetate, 1,2-dichloroethylene (DCE), acetonitrile, and methyl ethyl ketone. In each case, the solvent was subsequently removed under vacuum and the dried precipitate was collected. The amount of 2-chloro-5- (chloromethyl) thiazole and 2-chloroallyl isothiocyanate was determined in each case. The results are shown in Table 2 below. A smaller amount of 2-chloroallyl isothiocyanate indicates that 2-chloro-5- (chloromethyl) thiazole has higher stability and less decomposition rate.
參照表2,可以看出在DMF中2-氯-5-氯甲基噻唑是高度穩定的,在DMF的存在下分解率小於6%。經比較,在其它溶劑中2-氯-5-氯甲基噻唑的分解率明顯更高。 Referring to Table 2, it can be seen that 2-chloro-5-chloromethylthiazole is highly stable in DMF, and the decomposition rate is less than 6% in the presence of DMF. By comparison, the decomposition rate of 2-chloro-5-chloromethylthiazole in other solvents is significantly higher.
Claims (13)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1409422.1A GB2511010B (en) | 2014-05-28 | 2014-05-28 | Method of producing thiamethoxam |
??1409422.1 | 2014-05-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201613913A TW201613913A (en) | 2016-04-16 |
TWI662032B true TWI662032B (en) | 2019-06-11 |
Family
ID=51177532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW104116747A TWI662032B (en) | 2014-05-28 | 2015-05-26 | Method of producing thiamethoxam |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN106029658B (en) |
AR (1) | AR100267A1 (en) |
GB (1) | GB2511010B (en) |
TW (1) | TWI662032B (en) |
WO (1) | WO2015180585A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104262286A (en) * | 2014-10-09 | 2015-01-07 | 山东科信生物化学有限公司 | Synthetic method of thiamethoxam intermediate 3-methyl-4-nitroiminoperhydro-1,3,5-oxadiazine |
CN107400123A (en) * | 2017-08-28 | 2017-11-28 | 江苏绿叶农化有限公司 | A kind of production method of Diacloden |
CN107501256B (en) * | 2017-09-21 | 2020-03-31 | 北京怡力生物科技有限公司 | Preparation method of high-purity thiamethoxam |
CN107698578A (en) * | 2017-10-31 | 2018-02-16 | 江苏绿叶农化有限公司 | A kind of preparation method of Diacloden |
EP3480196A1 (en) * | 2017-11-02 | 2019-05-08 | Jiangsu Rotam Chemistry Co., Ltd | Process for the preparation of thiamethoxam |
CN108164522B (en) * | 2018-02-13 | 2020-02-18 | 浙江永太科技股份有限公司 | Synthetic method of thiamethoxam |
CN110981866B (en) * | 2019-12-17 | 2022-08-12 | 邯郸市瑞田农药有限公司 | Thiamethoxam production method and extracting agent |
CN113004218A (en) * | 2020-12-10 | 2021-06-22 | 怀仁市普惠生物科技有限公司 | Preparation method of dichloro pentachloromethyl thiazole |
CN113121465A (en) * | 2021-05-28 | 2021-07-16 | 安徽海顺化工有限公司 | Synthesis process of 2-chloro-5-chloromethyl thiazole |
CN115286624A (en) * | 2022-08-04 | 2022-11-04 | 内蒙古犇星化学有限公司 | Preparation method of thiamethoxam |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997010226A1 (en) * | 1995-09-11 | 1997-03-20 | Novartis Ag | Process for preparing a 2-chloro-5-chloromethyl-thiazole compound |
TWI254713B (en) * | 1999-06-23 | 2006-05-11 | Syngenta Participations Ag | Method of producing nitroguanidine-and nitroenamine derivatives |
CN102372702A (en) * | 2011-11-17 | 2012-03-14 | 安徽省化工研究院 | Preparation method for thiamethoxam |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1401646A (en) * | 2001-08-08 | 2003-03-12 | 南通江山农药化工股份有限公司 | Insecticidal compound and production process thereof |
GB2514927B (en) * | 2014-05-28 | 2019-04-17 | Rotam Agrochem Int Co Ltd | Thiamethoxam and uses thereof |
-
2014
- 2014-05-28 GB GB1409422.1A patent/GB2511010B/en active Active
-
2015
- 2015-05-04 AR ARP150101335A patent/AR100267A1/en active IP Right Grant
- 2015-05-21 CN CN201580009810.6A patent/CN106029658B/en active Active
- 2015-05-21 WO PCT/CN2015/079440 patent/WO2015180585A1/en active Application Filing
- 2015-05-26 TW TW104116747A patent/TWI662032B/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997010226A1 (en) * | 1995-09-11 | 1997-03-20 | Novartis Ag | Process for preparing a 2-chloro-5-chloromethyl-thiazole compound |
TWI254713B (en) * | 1999-06-23 | 2006-05-11 | Syngenta Participations Ag | Method of producing nitroguanidine-and nitroenamine derivatives |
CN102372702A (en) * | 2011-11-17 | 2012-03-14 | 安徽省化工研究院 | Preparation method for thiamethoxam |
Also Published As
Publication number | Publication date |
---|---|
WO2015180585A9 (en) | 2016-12-15 |
GB201409422D0 (en) | 2014-07-09 |
CN106029658B (en) | 2019-08-16 |
AR100267A1 (en) | 2016-09-21 |
GB2511010A (en) | 2014-08-20 |
TW201613913A (en) | 2016-04-16 |
GB2511010B (en) | 2017-05-03 |
WO2015180585A1 (en) | 2015-12-03 |
CN106029658A (en) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI662032B (en) | Method of producing thiamethoxam | |
KR20100014384A (en) | Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines | |
WO2018029641A1 (en) | METHOD OF MANUFACTURING 4-CHLORO-7H-PYRROLO[2,3-d]PYRIMIDINE | |
JP3268461B2 (en) | Method for producing nitroguanidine derivative | |
CN107043359A (en) | A kind of preparation method of prothioconazoles intermediate | |
CN110878084A (en) | Preparation method of nicosulfuron original drug | |
KR20120014005A (en) | Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine | |
JP5266944B2 (en) | Method for separating and purifying α-unsaturated amine compound | |
CZ20023395A3 (en) | Novel preparation process of torsemide intermediate | |
US10053420B2 (en) | Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine | |
WO1985000037A1 (en) | 4-chloro-4-methyl-5-methylene-1,3-dioxolan-2-one | |
JP4231556B2 (en) | Process for producing 1,3-disubstituted 2-nitroguanidine | |
JP5078211B2 (en) | Method for producing heterocyclic compound | |
BR112016027652B1 (en) | METHOD TO PRODUCE THIAMETOXAM | |
JP3098100B2 (en) | Method for producing 2-chloro-5-aminomethylpyridines | |
EP2835371B1 (en) | Industrial method for manufacturing high-purity methiozoline | |
JP4545152B2 (en) | Process for producing N-substituted 3β-aminonortropane | |
CN109721529B (en) | Simple preparation method of 2, 5-dichloropyridine | |
KR101348304B1 (en) | Method of preparing of (2Z)-3-[(6-methylpyridin-3-yl)methyl-1,3-thiazolidin-2-ylidene]cyanamice | |
JP2659587B2 (en) | 4-aziridinyl pyrimidine derivatives and their production | |
JP2653138B2 (en) | Haloallylfuran carbinols and their preparation | |
JP2759809B2 (en) | Process for producing E-isomer of imidazole derivative | |
EP0346881B1 (en) | A process for producing furylpropargylcarbinol and a derivate thereof | |
TWI542578B (en) | Preparation of Benzyl Nicotinic Acid Benzyl Ester Derivatives | |
JPS6248681A (en) | Production of nitromethylene derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |